Analysis of hospitalization of people with hemophilia-12 years of experience in a single center.

Cuiyun QuWei LiuLingling ChenLei ZhangFeng Xue Renchi Yang

Published in: Research and practice in thrombosis and haemostasis (2022)

For hemophilia, the most dominant cost during hospitalization was on clotting factor concentrates. Diagnosed HA and inhibitor positivity increased the global cost.

Keyphrases